LONDON--(BUSINESS WIRE)--Technavio has announced the top six leading vendors in their recent global analgesics market report. This research report also lists 35 other prominent vendors that are expected to impact the market during the forecast period.
Competitive vendor landscape
The global analgesics market is highly fragmented with the presence of numerous small and large vendors. The market at present is dominated by the major players. However, occasional spurts of competition have been witnessed among the local manufacturers present in various countries. Vendors are participating in strategic alliances to market and manufacture drugs. New players are expected to enter this market due to the presence of huge growth opportunities.
Pfizer, one of the top leading vendors in the market dominated the analgesics market with a share of more than 19%. Its dominant position is evident from its leading products, such as Lyrica, which reported revenue of USD 4.83 billion, and Celebrex, which reported revenue of USD 0.83 billion in 2015, respectively. Bayer HealthCare, with a share of over 3.11%, and Sanofi, with 3.1%, were the nearest competitors to Pfizer. Both the companies have a robust analgesic portfolio.
According to Barath Palada, a lead analyst at Technavio for research on central nervous system, “Increased use of online resources for health information is becoming a popular trend among end-users with the advent of the Internet. Likewise, with growing demand, e-commerce portals are targeting these potential customers and are collaborating with manufacturers to maximize their sales. Manufacturers and retailers are shifting their marketing strategy to the online platform to achieve high-volume sales and offer convenience and comfort for end-users. This strategy will also aid manufacturers to enhance their market share and withstand the tough competition in the market.”
Request for sample report: http://goo.gl/yR3jUZ
Top six analgesics market vendors
Pfizer
Pfizer was formed in 1849 and is headquartered in New York, US. It is a research-based biopharmaceutical company that produces, manufactures, and develops pharmaceutical products for various therapy areas, including arthritis, cardiovascular, metabolic disorders, infectious, and respiratory. In FY2015, the company reported net sales of USD 48.85 billion and spent USD 7.69 billion on R&D.
The company has an established presence in the global analgesic drugs market with its offerings such as Lyrica, Celebrex, Relpax, and Advil Migraine.
Bayer Healthcare
Bayer HealthCare was formed in 1863 and is headquartered in Leverkusen, Germany. The company researches, develops, manufactures, and sells pharmaceuticals, vaccines, and small components for human and animal health worldwide. In FY2015, the company generated revenue of USD 25.38 billion and spent USD 3.14 billion on R&D
Top-selling drugs
| Products | Sales 2015 (USD millions) | ||||
| Aspirin | 525 | ||||
| Aleve | 458.4 |
Sanofi
Sanofi was established in 1973 and is headquartered at Paris, France. The company researches, develops, and markets therapeutic solutions and healthcare products. In FY2015, it generated USD 41.1 billion and its R&D expenses were USD 5.83 billion.
Endo International
Endo International was formed in 1997 and is headquartered in Dublin, Ireland. The company researches, develops, manufactures, and markets branded and generic pharmaceuticals worldwide. In FY2014, the company reported revenue of USD 3.26 billion and spent USD 102.19 million on its R&D.
The company has an established presence in the global analgesics market with its range of offerings such as Opana ER, Lidoderm, Percocet, Voltaren, Sumavel DosePro, and Frova.
Johnson & Johnson
Johnson & Johnson was founded in 1887 and is headquartered in New Brunswick, New Jersey, the US. The company researches, develops, and markets products across various therapy areas, including immunology, infectious diseases, neuroscience, oncology, and metabolic and cardiovascular diseases. It also develops and sells medical devices and consumer care products. It recorded revenue of USD 70.07 billion in FY2015.
The company has an established presence in the global analgesics market with offerings such as Tylenol, Motrin, and Dolormin.
Purdue Pharma
Purdue Pharma was founded in 1892 and is headquartered in Stamford, Connecticut, US. The company researches, develops, produces, and markets prescription and OTC medicines and healthcare products.
Purdue Pharma has an established presence in the global analgesic drugs market with offerings such as Butrans, Dilaudid, Hysingla ER, MS Contin, and OxyContin.
Browse Related Reports:
- Global Osteoarthritis Pain Drugs Market 2016-2020
- Global Rheumatoid Arthritis Drugs Market 2016-2020
- Global Pain Management Drugs Market 2016-2020
Do you need a report on a market in a specific geographical cluster or country but can’t find what you’re looking for? Don’t worry, Technavio also takes client requests. Please contact enquiry@technavio.com with your requirements and our analysts will be happy to create a customized report just for you.
About Technavio
Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.
Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.
If you are interested in more information, please contact our media team at media@technavio.com.
